Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Costs and expenses        
Operating costs $ 6,449 $ 2,411 $ 10,497 $ 4,541
Research and development 250 224 589 771
Selling, general and administrative 12,954 7,259 27,701 14,883
Total operating costs and expenses 19,653 9,894 38,787 20,195
Interest (income) expense (176) 1,836 268 3,879
Change in fair value of warrants (4,495) (359) 1,340 13,262
Other expense (income) 22 (312) 41 (203)
Total other expense (4,649) 1,165 1,649 16,938
Net loss $ (15,004) $ (11,059) $ (40,436) $ (37,133)
Loss per share        
Basic (in usd per share) $ (0.09) $ (0.09) $ (0.27) $ (0.44)
Diluted (in usd per share) $ (0.09) $ (0.09) $ (0.27) $ (0.44)
Weighted average common shares        
Basic (in shares) 163,249 117,346 148,413 84,284
Diluted (in shares) 163,249 117,346 148,413 84,284
Other comprehensive loss        
Unrealized loss on debt securities available for sale $ (460) $ (106) $ (800) $ (106)
Total comprehensive loss $ (15,464) $ (11,165) $ (41,236) $ (37,239)